Q1 2022 Aarti Drugs Ltd Earnings Call Transcript
I now hand the conference over to Mr. Adhish Patil, CFO, Aarti Drugs Limited.
Thank you and over to you sir.
Thank you. Hello everyone, and a very warm welcome to all of you present on the call to discuss our financial results for the first quarter of financial year 2022. So from Aarti Drugs Limited today we have our Joint Managing Director, Mr. Harshit Savla, then whole time Director Mr. Harit Shah, and myself CFO of the company.
We hope all of you and your loved ones are healthy and safe in the wake of ongoing pandemic answers across the country. The downward trend of COVID-19 cases is certainly a good sign. And we sincerely hope that the pandemic gets over soon, I would also like to highlight that the company has not faced any major disruption in terms of supply chain or plant shutdowns due to ongoing flood situation in Maharashtra.
We are happy to share that Aarti Drugs delivered a resilient performance despite facing multiple headwinds during the quarter, our consolidated revenue stood at
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
